361 related articles for article (PubMed ID: 9317166)
21. Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression.
Leiden JM; Karpinski BA; Gottschalk L; Kornbluth J
J Immunol; 1989 Mar; 142(6):2140-7. PubMed ID: 2493507
[TBL] [Abstract][Full Text] [Related]
22. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression.
Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T
Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970
[TBL] [Abstract][Full Text] [Related]
23. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
[TBL] [Abstract][Full Text] [Related]
24. The NKB1 and HP-3E4 NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules.
Lanier LL; Gumperz JE; Parham P; Melero I; López-Botet M; Phillips JH
J Immunol; 1995 Apr; 154(7):3320-7. PubMed ID: 7897214
[TBL] [Abstract][Full Text] [Related]
25. NK cells from human MHC class I (HLA-B) transgenic mice do not mediate hybrid resistance killing against parental nontransgenic cells.
Kung SK; Su RC; Graham JJ; Chamberlain JW; Miller RG
J Immunol; 1998 Jan; 160(2):674-80. PubMed ID: 9551902
[TBL] [Abstract][Full Text] [Related]
26. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
27. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity.
Le Bouteiller P; Barakonyi A; Giustiniani J; Lenfant F; Marie-Cardine A; Aguerre-Girr M; Rabot M; Hilgert I; Mami-Chouaib F; Tabiasco J; Boumsell L; Bensussan A
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16963-8. PubMed ID: 12486241
[TBL] [Abstract][Full Text] [Related]
28. Co-effect of HLA-G1 and glycosyltransferases in reducing NK cell-mediated pig endothelial cell lysis.
Miyagawa S; Nakai R; Matsunami K; Kusama T; Shirakura R
Transpl Immunol; 2003; 11(2):147-53. PubMed ID: 12799197
[TBL] [Abstract][Full Text] [Related]
29. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
Kurago ZB; Lutz CT; Smith KD; Colonna M
J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
[TBL] [Abstract][Full Text] [Related]
30. General role of HLA class I molecules in the protection of target cells from lysis by natural killer cells: evidence that the free heavy chains of class I molecules are not sufficient to mediate the protective effect.
Ciccone E; Pende D; Nanni L; Di Donato C; Viale O; Beretta A; Vitale M; Sivori S; Moretta A; Moretta L
Int Immunol; 1995 Mar; 7(3):393-400. PubMed ID: 7794819
[TBL] [Abstract][Full Text] [Related]
31. Human cytomegalovirus UL18 alleviated human NK-mediated swine endothelial cell lysis.
Kim JS; Choi SE; Yun IH; Kim JY; Ahn C; Kim SJ; Ha J; Hwang ES; Cha CY; Miyagawa S; Park CG
Biochem Biophys Res Commun; 2004 Feb; 315(1):144-50. PubMed ID: 15013438
[TBL] [Abstract][Full Text] [Related]
32. Threonine 80 on HLA-B27 confers protection against lysis by a group of natural killer clones.
Luque I; Solana R; Galiani MD; González R; García F; López de Castro JA; Peña J
Eur J Immunol; 1996 Aug; 26(8):1974-7. PubMed ID: 8765048
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals.
Grau R; Lang KS; Wernet D; Lang P; Niethammer D; Pusch CM; Handgretinger R
Exp Mol Pathol; 2004 Apr; 76(2):90-8. PubMed ID: 15010286
[TBL] [Abstract][Full Text] [Related]
34. Lack of galactose-alpha-1,3-galactose expression on porcine endothelial cells prevents complement-induced lysis but not direct xenogeneic NK cytotoxicity.
Baumann BC; Forte P; Hawley RJ; Rieben R; Schneider MK; Seebach JD
J Immunol; 2004 May; 172(10):6460-7. PubMed ID: 15128838
[TBL] [Abstract][Full Text] [Related]
35. Natural killer cells lyse autologous herpes simplex virus infected targets using cytolytic mechanisms distributed clonotypically.
Pietra G; Semino C; Cagnoni F; Boni L; Cangemi G; Frumento G; Melioli G
J Med Virol; 2000 Nov; 62(3):354-63. PubMed ID: 11055246
[TBL] [Abstract][Full Text] [Related]
36. Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene.
Gorelik E; Jay G; Kwiatkowski B; Herberman RB
J Immunol; 1990 Sep; 145(5):1621-32. PubMed ID: 2384672
[TBL] [Abstract][Full Text] [Related]
37. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA.
Fletcher JM; Prentice HG; Grundy JE
J Immunol; 1998 Sep; 161(5):2365-74. PubMed ID: 9725232
[TBL] [Abstract][Full Text] [Related]
38. Studies of sublines selected for loss of HLA expression from an EBV-transformed lymphoblastoid cell line. Changes in sensitivity to cytotoxic T cells activated by allostimulation and natural killer cells activated by IFN or IL-2.
Ohlén C; Bejarano MT; Grönberg A; Torsteinsdottir S; Franksson L; Ljunggren HG; Klein E; Klein G; Kärre K
J Immunol; 1989 May; 142(9):3336-41. PubMed ID: 2468716
[TBL] [Abstract][Full Text] [Related]
39. HLA-G inhibits rolling adhesion of activated human NK cells on porcine endothelial cells.
Forte P; Pazmany L; Matter-Reissmann UB; Stussi G; Schneider MK; Seebach JD
J Immunol; 2001 Nov; 167(10):6002-8. PubMed ID: 11698480
[TBL] [Abstract][Full Text] [Related]
40. Negative regulation of rat natural killer cell activity by major histocompatibility complex class I recognition.
Kraus E; Lambracht D; Wonigeit K; Hünig T
Eur J Immunol; 1996 Nov; 26(11):2582-6. PubMed ID: 8921942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
